| Process for purifying fusion proteins |
2023-3-24 |
2023-9-28 |
|
| Novel il-18 variants |
2022-12-22 |
2023-6-29 |
|
| Novel fusion protein specific for ox40 and pd-l1 |
2022-11-18 |
2023-5-25 |
|
| Proteins specific for cd137 |
2022-9-26 |
2022-11-30 |
|
| Muteins of human lipocalin 2 (lcn2,hngal) with affinity for given target |
2022-7-01 |
2022-10-19 |
|
| Methods for preventing or treating certain disorders by inhibiting binding of … |
2022-6-14 |
2023-1-19 |
|
| Engineered t cells and uses therefor |
2022-5-24 |
2022-9-22 |
|
| Lipocalin muteins with binding affinity for ox40 |
2022-5-18 |
2022-11-24 |
|
| Novel lipocalin muteins specific for connective tissue growth factor (ctgf) |
2022-4-08 |
2022-10-13 |
|
| Novel lipocalin muteins specific for connective tissue growth factor (ctgf) |
2022-4-08 |
2022-10-13 |
|
| Tumor treatment with a 4-1bb/her2-bispecific agent and a her2-targeted tyrosine … |
2022-3-24 |
2022-9-29 |
|
| Her2/4-1bb bispecific fusion proteins for the treatment of cancer |
2022-3-23 |
2022-9-29 |
|
| Her2/4-1bb bispecific fusion proteins for the treatment of cancer |
2022-3-23 |
2022-9-29 |
|
| Lipocalin muteins with binding affinity for lag-3 |
2021-10-12 |
2022-3-31 |
|
| Lipocalin muteins with binding affinity for LAG-3 |
2021-10-12 |
2023-10-03 |
2023-10-03 |
| Biomarker methods and uses |
2021-9-17 |
2022-3-24 |
|
| Muteins of human lipocalin 2 with affinity for glypican-3 (gpc3) |
2021-8-04 |
2021-12-09 |
|
| Novel fusion proteins specific for cd137 and gpc3 |
2021-7-07 |
2021-8-31 |
|
| Multimeric immunomodulators targeting 4-1BB |
2021-6-04 |
2023-6-09 |
|
| Anti-cancer fusion polypeptide |
2021-2-05 |
2021-12-30 |
|
| New fusion proteins specific for cd137 and pd-l1 |
2021-1-26 |
2021-8-13 |
|
| Tear lipocalin muteins binding il-4 r alpha |
2020-12-16 |
2021-7-01 |
|
| Anti-cancer fusion polypeptide |
2020-11-12 |
2021-7-01 |
|
| Her2/4-1bb bispecific fusion proteins for the treatment of cancer |
2020-11-04 |
2021-5-14 |
|
| Novel specific-binding polypeptides and uses thereof |
2020-8-20 |
2021-3-04 |
|
| Inhaled administration of lipocalin muteins |
2020-3-27 |
2020-10-08 |
|
| Lipocalin mutein for treatment of asthma |
2020-3-25 |
2022-6-23 |
|
| FUSION PROTEINS, NUCLEIC ACID MOLECULE, PRODUCTION METHODS, TO SIMULTANEOUSLY … |
2020-2-25 |
2021-10-19 |
|
| Novel interleukin-17a-specific and interleukin-23-specific binding polypeptides … |
2019-11-21 |
2020-5-14 |
|
| Novel proteins specific for angiogenesis |
2019-11-13 |
2020-5-07 |
|
| Novel proteins specific for lag-3 |
2019-10-30 |
2020-2-13 |
|
| Combination therapies comprising cd137/her2 bispecific agents and pd-1 axis … |
2019-8-27 |
2020-3-05 |
|
| NEW FUSION PROTEIN SPECIFIC TO CD137 AND PD-L1 |
2019-7-31 |
2022-1-26 |
|
| Novel fusion protein specific for cd137 and pd-l1 |
2019-7-31 |
2023-6-29 |
|
| Humanized anti-pd-1 antibodies and uses thereof |
2019-7-26 |
2020-1-30 |
|
| Proteins specific for calcitonin gene-related peptide |
2019-7-08 |
2021-6-15 |
2021-6-15 |
| Fusion molecules |
2019-4-24 |
2021-3-16 |
2021-3-16 |
| Novel fusion polypeptide specific for lag-3 and pd-1 |
2018-10-23 |
2019-7-19 |
|
| Novel proteins specific for pyoverdine and pyochelin |
2018-8-14 |
2018-12-27 |
|
| Muteins of tear lipocalin and methods for obtaining the same |
2018-7-10 |
2019-1-17 |
|
| Methods for preventing or treating disorders by increasing bioavailability of … |
2018-3-28 |
2018-11-01 |
|
| Novel fusion polypeptides specific for lag-3 and pd-1 |
2018-1-18 |
2018-7-26 |
|
| Proteins specific for cd137 |
2017-11-08 |
2018-5-17 |
|
| Methods for preventing, treating or diagnosing disorders |
2017-10-20 |
2018-5-17 |
|
| Human neutrophil gelatinase-associated lipocalin (hngal) muteins that bind … |
2017-7-07 |
2017-12-28 |
|
| Novel binding proteins for pcsk9 |
2017-2-28 |
2017-6-22 |
|
| Lipocalin muteins with binding-affinity for glypican-3 (gpc-3) and use of … |
2016-11-02 |
2017-3-09 |
|
| Anti-cancer fusion polypeptide |
2016-5-18 |
2023-2-17 |
|
| Muteins with tear lipocalin having affinity to human c-met receptor tyrosine … |
2015-12-14 |
2016-7-14 |
|
| Recombinant bacterial lipocalin blc and uses thereof |
2015-2-12 |
2015-7-09 |
|
| Multi-specific polypeptide useful for localized tumor immunomodulation |
2015-1-12 |
2019-9-19 |
2019-9-19 |
| Novel lipocalin-mutein assays for measuring hepcidin concentration |
2014-2-05 |
2015-7-02 |
|
| Controlled release formulation of lipocalin mutein |
2012-8-08 |
2015-9-09 |
2015-9-09 |
| MUTEINES OF HUMAN LIPOCALIN 2 WITH AFFINITY FOR CTLA-4 |
2011-12-02 |
2017-10-23 |
2017-10-23 |
| Muteins of human lipocalin 2 with affinity for Glypican-3 (GPC3) |
2011-11-15 |
2013-5-23 |
|
| Muteins of tear lipocalin and methods for obtaining the same |
2011-6-23 |
2011-7-14 |
|
| Muteins of human tear lipocalin |
2009-8-19 |
2011-2-22 |
2011-2-22 |
| Muteins of tear lipocalin and methods for obtaining the same |
2007-8-01 |
2009-8-26 |
|
| Muteins of apolipoprotein D |
2006-9-25 |
2007-1-25 |
|
| Compound with affinity for the cytotoxic T lymphocyte-associated antigen (CTLA- … |
2005-11-25 |
2015-7-29 |
|
| Muteins of a bilin-binding protein with affinity for a given target |
2003-8-25 |
2010-4-06 |
2010-4-06 |
| Soluble truncated polypeptides of the nogo-a protein |
2002-10-31 |
2006-12-21 |
|
| Muteins of human neutrophil gelatinase-associated lipocalin and related … |
2002-9-18 |
2007-7-11 |
2007-7-11 |
| Muteins of human neutrophil gelatinase-associated lipocalin and related … |
2002-9-18 |
2003-6-26 |
|
| Nouvelles muteines de lipocaline specifiques au facteur de croissance des … |
2022-4-08 |
2022-10-13 |
|
| Proteínas de fusão, molécula de ácido nucleico, métodos de produção, de ativar … |
2020-2-25 |
2021-10-19 |
|